Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...

The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...

In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was “taking these difficult but necessary ...

Me (ME), the company that popularized at-home DNA tests, announced on Tuesday that its sales took a hit during its most ...

"We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core ...

Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...

Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...

In a significant move to stabilize its operations, 23andMe has announced the layoff of 200 employees, representing a ...

As founder and CEO Anne Wojcicki struggles to take the company private, 200 jobs are cut as part of its restructuring plan.